2016
DOI: 10.1007/978-1-4939-6730-8_4
|View full text |Cite
|
Sign up to set email alerts
|

LC-MSE, Multiplex MS/MS, Ion Mobility, and Label-Free Quantitation in Clinical Proteomics

Abstract: Proteomic tools can only be implemented in clinical settings if high-throughput, automated, sensitive, and accurate methods are developed. This has driven researchers to the edge of mass spectrometry (MS)-based proteomics capacity. Here we provide an overview of recent achievements in mass spectrometric technologies and instruments. This includes development of high and ultra definition-MS (HDMS and UDMS) through implementation of ion mobility (IM) MS towards sensitive and accurate label-free proteomics using … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 49 publications
0
29
0
Order By: Relevance
“…Synapt G2-Si was calibrated with [Glu1]-fibrinopeptide, [M+2H] 2+ = 785.84261 at � 1 ppm. The results generated from Progenesis Software were exported to � .xlsx files to verify two levels of data quality control for label-free experiments (peptide and protein level) according to the figures of merit (FOM) described by Souza et al [31]. All proteins considered with differential interaction with Akt presented at least a ratio ±1.2 (expressed as a base 2 logarithm); it means that these proteins had at least ± 2.29-absolute fold change interaction (diminished or increased) with Akt in cardiomyocytes of MetS vs control rats.…”
Section: Label-free Mass Spectrometrymentioning
confidence: 99%
“…Synapt G2-Si was calibrated with [Glu1]-fibrinopeptide, [M+2H] 2+ = 785.84261 at � 1 ppm. The results generated from Progenesis Software were exported to � .xlsx files to verify two levels of data quality control for label-free experiments (peptide and protein level) according to the figures of merit (FOM) described by Souza et al [31]. All proteins considered with differential interaction with Akt presented at least a ratio ±1.2 (expressed as a base 2 logarithm); it means that these proteins had at least ± 2.29-absolute fold change interaction (diminished or increased) with Akt in cardiomyocytes of MetS vs control rats.…”
Section: Label-free Mass Spectrometrymentioning
confidence: 99%
“…MS acquisition. Prior to injection, each sample was acquired as "scouting runs" to access the total ion counts, and a stoichiometric normalization between conditions was conducted (75). Peptides were injected into a 2D-RP/RP ACQUITY UPLC M-Class System (Waters, Milford, MA), tandem to a Synapt G2-Si mass spectrometer (Waters, Manchester, U.K.).…”
Section: Protein Quantitative Analyses By Msmentioning
confidence: 99%
“…The used proteomic approach revealed a broad dynamic range of detected proteins with more than seven orders of magnitude as expected for this biological matrix and considering the instrument technology. More detailed information can be found in Supplemental Table II and references (75,81,88).…”
Section: Label-free Quantitative Ms: Quality Of Proteome Datamentioning
confidence: 99%
“…Qualitative and quantitative proteomic analysis were performed on a 2D-LC-MS/MS system with ion-mobility-enhanced data-independent acquisitions (Souza et al 2017). Peptides were injected into a two-dimensional reverse phase liquid chromatography using an Acquity UPLC M-Class System (Waters Corporation, Milford, MA) coupled to a Synapt G2-Si mass spectrometer (Waters Corporation, Milford, MA).…”
Section: Liquid Chromatography-mass Spectrometrymentioning
confidence: 99%
“…Qualitative and quantitative proteomic analysis were performed on a 2D-LC-MS/MS system with ion-mobility-enhanced data-independent acquisitions (Souza et al, 2017 Samples were all run in technical and biological triplicates.…”
Section: Liquid Chromatography-mass Spectrometrymentioning
confidence: 99%